Release Date	Request Code	Change Type	NCI Code	CDISC Term Type	CDISC Codelist (Short Name)	CDISC Codelist (Long Name)	Change Summary	Original	New	Change Implementation Instructions
2022-12-16	CDISC-5132	Add	C160924	CDISC Codelist	SDTMIGRS	SDTMIG Version Response	Addition of new codelist	- - -	SDTMIGRS	
2022-12-16	CDISC-5132	Add	C161432	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.1.1	
2022-12-16	CDISC-5132	Add	C161433	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.1.2	
2022-12-16	CDISC-5132	Add	C161434	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	Version 3.1.2 Amendment 1	
2022-12-16	CDISC-5132	Add	C161435	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.1.3	
2022-12-16	CDISC-5132	Add	C161436	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.2	
2022-12-16	CDISC-5132	Add	C161437	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.3	
2022-12-16	CDISC-5132	Add	C189638	Term	SDTMIGRS	SDTMIG Version Response	Add new term to new codelist	- - -	3.4	
2022-12-16	CDISC-5653	Add	C191213	Term	STDNAM	Standard Name	Add new term to existing codelist	- - -	BIMO	
2022-12-16	CDISC-5899	Update	C49704	CDISC Definition	DICTNAM	Dictionary Name	Update CDISC Definition	A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event.	A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in cancer clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event.	
2022-12-16	CDISC-5899	Update	C70793	CDISC Definition	ORIGINS	Origin Source	Update CDISC Definition	An entity that is responsible for the initiation, management, and/or financing of a clinical study.	An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP]